HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Degradation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate in human leukemic myeloblasts and lymphoblasts.

Abstract
The intracellular half-life for retention of the active triphosphate metabolite 1-beta-D-arabinofuranosylcytosine 5'-triphosphate (araCTP) of 1-beta-D-arabinofuranosylcytosine was measured in vitro in blast cells from patients with acute myeloblastic leukemia, acute lymphoblastic leukemia, and T-cell lymphoblastic lymphoma. araCTP accumulation from 1 microM 1-beta-D-arabinofuranosylcytosine in leukemic blast cells was closely correlated with the nucleoside transport capacity as measured by equilibrium binding of [3H]nitrobenzylthioinosine. The half-life of araCTP retention was related to araCTP accumulation only when the level of araCTP was expressed as a percentage of total intracellular 1-beta-D-arabinofuranosylcytosine metabolites. Accumulation of 1-beta-D-arabinofuranosyluracil 5'-monophosphate was inversely related to the half-life of araCTP retention and directly related to dCMP deaminase activity in cell free extracts. No conversion of 1-beta-D-arabinofuranosyluracil to 1-beta-D-arabinofuranosyluracil 5'-monophosphate was detectable in intact cells. The end product of araCTP degradation was 1-beta-D-arabinofuranosyluracil and it is proposed that conversion of 1-beta-D-arabinofuranosylcytosine 5'-monophosphate to 1-beta-D-arabinofuranosyluracil 5'-monophosphate is a step in the degradative pathway of araCTP. However, it is the cells' nucleoside transport capacity which primarily determines the level of intracellular araCTP accumulation.
AuthorsG P Jamieson, L R Finch, M Snook, J S Wiley
JournalCancer research (Cancer Res) Vol. 47 Issue 12 Pg. 3130-5 (Jun 15 1987) ISSN: 0008-5472 [Print] United States
PMID3472653 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Arabinonucleotides
  • Thionucleosides
  • Cytarabine
  • Guanosine
  • 6-(4-nitrobenzylthio)guanosine
  • Arabinofuranosylcytosine Triphosphate
  • Thioinosine
  • DCMP Deaminase
  • 4-nitrobenzylthioinosine
Topics
  • Arabinofuranosylcytosine Triphosphate (metabolism)
  • Arabinonucleotides (metabolism)
  • Cytarabine (therapeutic use)
  • DCMP Deaminase (metabolism)
  • Guanosine (analogs & derivatives, pharmacology)
  • Half-Life
  • Humans
  • Kinetics
  • Leukemia, Lymphoid (metabolism)
  • Leukemia, Myeloid, Acute (metabolism)
  • Lymphocytes (metabolism)
  • Phosphorylation
  • Thioinosine (analogs & derivatives, pharmacology)
  • Thionucleosides (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: